StonvexLoading…
StonvexStonvexStonvexCore line items from MRAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $21.58M | $14.57M | $7.38M | $37.16M |
Operating Income | $-19.40M | $-16.34M | $-4.07M | $-27.98M |
Net Income | $-20.93M | $-17.37M | $-4.35M | $-28.75M |
EPS (Diluted) | $-1.96 | $-1.73 | $-0.46 | $-4.14 |
Total Assets | $19.61M | $22.22M | $30.09M | $31.68M |
Total Liabilities | $47.16M | $47.88M | $44.58M | $45.12M |
Cash & Equivalents | $830.00K | $1.29M | $851.00K | $1.15M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 13.75M | 11.04M | 10.31M | 7.96M |